Nuwellis Announces Acceptance Of New Single-Center Retrospective Study In Frontiers In Pediatrics Journal
Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces the acceptance of a new single-center retrospective study in Frontiers in
A medical company called Nuwellis had a study about their treatment accepted by a science journal, which means doctors and scientists think their research is worth sharing. This shows the company is doing real research to prove their medicine works, which is something investors watch when judging if a company has a real product.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.